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The course of systemic viral infections is determined
by the virus productivity of infected cell types and the
efficiency of virus dissemination throughout the host.
Here, we used a cell-type-specific virus labeling sys-
tem to quantitatively track virus progeny during
murine cytomegalovirus infection. We infected mice
that expressed Cre recombinase selectively in vas-
cular endothelial cells or hepatocytes with a murine
cytomegalovirus for which Cre-mediated recombina-
tion would generate a fluorescently labeled virus. We
showed that endothelial cells and hepatocytes pro-
duced virus after direct infection. However, in the
liver, the main contributor to viral load in the mouse,
most viruses were produced by directly infected
hepatocytes. Remarkably, although virus produced
in hepatocytes spread to hepatic endothelial cells
(and vice versa), there was no significant spread
from the liver to other organs. Thus, the cell type pro-
ducing the most viruses was not necessarily the one
responsible for virus dissemination within the host.
INTRODUCTION
Systemic virus infections are characterized by replication at the
entry site, followed by dissemination to and replication in sec-
ondary target organs, which then seed the virus to the final target
organs of disease (Knipe and Howley, 2001). The inability of the
host to limit virus production and dissemination in time is often
associated with disease. Therefore, the cell types responsible
for virus replication and dissemination are of central interest to
the understanding of viral pathogenesis.
Virus uptake and replication by defined cell types is usually an-
alyzed in cell culture. Cell lines, however, tend to lose properties
of the parental cells. Loss of cell-cell contacts, loss of extracel-
lular matrix, and the lack of growth factors and cytokines all
can alter cell physiology (Garlanda and Dejana, 1997). In addi-
tion, the permissiveness of certain cell types may depend on
the presence of other cell types (Nedrud and Wu, 1984). Finally,
certain viruses do not replicate in cell culture at all. Therefore, in
vivo studies are important. Although the detection of character-istic cytopathic effects, of viral transcripts and proteins, of an
increase in viral genome copy numbers, and of virus particles
serve as indicators of productive infection (Knipe and Howley,
2001), it is a challenge to quantify the virus progeny of a specific
cell type in vivo.
Organs that produce large amounts of infectious virus early
during infection are thought to disseminate the virus to other
sites where manifestations of infection appear later. This con-
cept was formulated by Frank Fenner based on studies with
mouse pox showing that after local infection, virus is first seen
in the skin, then in regional lymph nodes followed by liver and
spleen, before it finally returns to the skin producing the typical
rash (Fenner, 1949). He suggested that virus is distributed in a pri-
mary viremia from the initial site of infection to spleen and liver,
where it replicates to high virus loads followed by dissemination
via secondary viremia to other organs. This plausible model is
generally used to explain systemic virus infections (Knipe and
Howley, 2001; Flint, 2004).
Here, we revisited the concept of virus dissemination by
studying murine cytomegalovirus (MCMV) infection. The infec-
tion of mice with MCMV represents a model for the analysis of
replication, dissemination, and immune control of human CMV
(HCMV). HCMV, an important human pathogen, causes morbid-
ity and mortality in immunocompromised individuals such as
AIDS patients and organ transplant recipients. MCMV and
HCMV replicate in a broad spectrum of cell types in vivo, includ-
ing vascular endothelial cells (EC) and hepatocytes (Hc). Like
other viruses that cause systemic infection, MCMV has been de-
scribed to disseminate from an initial peripheral site of entry to
spleen and liver, and secondary viremia is considered to distrib-
ute the virus from liver and spleen to other organs (Collins et al.,
1994).
In order to trace virus progeny produced by a specific cell type
in the host, virus tagging by the Cre-loxP system should be an
applicable strategy. Cre recombinase catalyzes the recombina-
tion of two directly repeated loxP sites leading to the excision of
an intervening stop cassette, and this allows the control of gene
expression in a temporal and spatial manner in vivo (Lewandoski,
2001). The Cre-loxP system has already been applied to activate
cell-type-specific expression of viral genes in vivo (DeFalco
et al., 2001). Here, we show that the Cre-loxP system can serve
to estimate virus production, cell-to-cell spread, and long-dis-
tance dissemination originating from defined cell types in vivo.
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that produce the bulk of infectious virus during acute infection
necessarily also play a major role in dissemination.
RESULTS
A recombinant murine cytomegalovirus (MCMV) with a Cre-in-
ducible fluorescent reporter EGFP was constructed by insertion
of a cassette into the BAC-clonedMCMV genome (Wagner et al.,
1999) comprising a loxP-flanked (floxed) transcriptional stop
sequence between the HCMV major immediate-early promoter
and the EGFP coding sequence. To reduce genome oversize,
the cassette replaced parts of the m157 gene resulting in
MCMV-Dm157-flox-egfp (MCMV-flox, Figure 1A). The gene
product of m157 is a ligand for the activating NK cell receptor
Ly49H. Its function is absent in MCMV strains isolated from
wild mice and is lost after passage of MCMV through Ly49H+
mice (Voigt et al., 2003). Deletion of m157 reduces NK cell-
mediated immune control in C57BL/6 mice (Bubic et al., 2004).
In cells expressing Cre, the transcriptional stop sequence is
excised, yielding the EGFP expressing recombined virus
MCMV-Dm157-rec-egfp (MCMV-rec). The number of reporter-
tagged infectious viruses in organ homogenates of cre trans-
genic mice is determined by plaque assay (Figure 1B). After
one round of virus replication, the number of EGFP+ plaques rep-
resents the absolute productivity of the Cre-expressing cell type,
and the comparison with the number of EGFP plaques reveals
its relative contribution to the total virus productivity in a given or-
gan. Furthermore, analysis of EGFP+ cells and of recombined vi-
rus progeny over time should demonstrate viral spread between
different cell types within an organ as well as virus dissemination
between organs (Figure 1C).
MCMV-flox and MCMV-rec replicated to comparable titers in
different organs within 10 days of infection when injected sepa-
rately or together into C57BL/6 mice (Figure S1 available online).
Significant attenuation of MCMV-rec could mainly be seen in
lungs at 10 days p.i. In line with this is a previous study showing
that EGFP is onlyminimally immunogenic in C57BL/6mice (Skel-
ton et al., 2001). Most importantly, there was no evidence for
marker activation inMCMV-flox in theabsenceofCre. In addition,
the marker was stably maintained in the progeny as demon-
strated by 100% EGFP+ plaques in C57BL/6 mice infected with
MCMV-rec (data not shown). Hence, the mutant pair fulfilled
the criteria for studying the contribution of Cre-expressing cell
types to virus production, spread, and dissemination during
acute infection. Between experiments, virus clearance in individ-
ual organs was slightly variable (compare Figures S1 and S7 with
Figure 3A).
Conditional Mutagenesis Permits Cell-Type-Specific
Labeling of Virus Progeny In Vivo
Vascular endothelial cells (EC) are present in all organs and are
regarded as a major source of viremic CMV (Gerna et al.,
2004). To study MCMV replication in EC, we used Tie2-cre
mice expressing Cre recombinase under control of the Tie2 pro-
moter in vascular EC (Constien et al., 2001). To mimic the
Figure 1. Tracing of Cell-Type-Specific Progeny by Conditional
Virus Recombination
(A) A Cre-inducible expression cassette is inserted into the m157 gene of the
MCMVgenome, resulting inMCMV-Dm157-flox-egfp (MCMV-flox). Cre-medi-
ated removal of a transcriptional stop sequence flanked by loxP sites (floxed)
leads to expression of EGFP under control of the major immediate early
promoter of HCMV (MCMV-rec).
(B) Schematic setup of experiments and analysis. Transgenic mice expressing
Cre recombinase under control of a cell-type-specific promoter are infected
with the MCMV-flox reporter virus. After different time points postinfection,
the amount of MCMV-rec and MCMV-flox plaque forming units (PFU) in vari-
ous organs (org1 and org2) was determined by plaque assay. The graph de-
picts total (MCMV-rec plus MCMV-flox) virus load per gram organ for individ-
ual mice as open circles that refer to the logarithmic scale on the right hand
side. Horizontal bars mark mean values and dotted lines indicate detection
limits of total virus load. Green columns refer to the linear scale on the left
hand side and show the mean percentage of EGFP+ plaques, with the stan-
dard deviation indicated by vertical bars. In all subsequent figures where per-
centages of EGFP+ plaques are depicted in parallel to total virus load, columns
are not shown in green but in gray or white.
(C) Cell-type-specific Cre-mediated recombination of viral genomes in cre
transgenic mice allows identification and quantification of labeled infected
cells and recombined virus progeny produced by defined cell types (e.g.,
endothelial cells). Spread of labeled virus to Cre-negative neighboring cells
and dissemination to other organs can be analyzed.
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the intravenous (i.v.) route, the so-called passive viremia. In ac-
cordance with the ubiquitous presence of endothelia, MCMV-
rec was found on day 3 postinfection (p.i.) in all organs tested
(Figure 2A). Notably, the proportion of MCMV-rec differed be-
tween organs and was found to be high (80%) in lungs and
heart, intermediate in spleen and kidney (50% and 20%, re-
spectively), and low (<10%) in the liver. By using a second, inde-
pendently generated mouse strain (Koni et al., 2001) a compara-
ble hierarchy of organ specific relevance of EC to virus
production was obtained, which indicated that independent
Tie2-cre transgenic mouse lines do not differ with regard to
cell-type-specific Cre expression and production of recombined
virus (Figure S2). A potential contribution of Cre-expressing bone
marrow (BM) cells of Tie2-cre mice (Constien et al., 2001) was
excluded by the absence of MCMV-rec in nontransgenic mice
transplanted with Tie2-cre BM (Tie2/Ptprc) as well as by a
similar ratio of MCMV-rec in Tie2-cre mice reconstituted with
nontransgenic BM (Ptprc/Tie2) compared to Tie2-cre mice
and Tie2/Tie2 BM chimeras (Figure S3).
Hepatocytes (Hc) are prominent targets of MCMV infection in
the liver as defined by immunohistology and in situ hybridization
(reviewed by Holtappels et al., 2006). In order to compare the
contribution of Hc with that of other liver cells comprising not
only EC but also Kupffer cells, Pit cells, and Ito cells, mice ex-
pressing Cre in Hc under control of the albumin promoter (Alb-
cre; Postic et al., 1999) were infected with MCMV-flox. As shown
in Figure 2B,70% of the total infectivity in the liver represented
progeny recombined in Hc, suggesting that Hc are the main pro-
ducer cell type. In contrast to the Tie2-cremodel,MCMV-recwas
virtually absent from organs other than the liver on day 3 after
infection of Alb-cre mice. This finding excluded an expression
of Cre recombinase in nonhepatic tissues. Remarkably, it also re-
vealed that Hc-derived MCMV-rec did not disseminate from the
liver to other organs within 3 days of infection. Comparison of
the relative amount ofMCMV-rec from hemizygous and homozy-
gous Alb-cremice did not indicate a cre gene dose effect on the
recombination rate (Figure S4). The relative contribution of EC
Figure 2. EC and Hc Are Important Cell Types for Replication of
MCMV
Tie2-cre+/ (A) or Alb-cre+/ (B) mice were infected i.v. with 106 PFU of MCMV-
flox. Lungs (lu), heart (he), kidney (ki), liver (li), and spleen (sp) were analyzed on
day 3 p.i. as described in Figure 1B. (A) p < 0.005 (a versus c, a versus d, a ver-
sus e, b versus c, b versus d, b versus e, and d versus e); p < 0.05 (c versus e);
p > 0.1 (a versus b and c versus d). (B) p < 0.01 (f versus i, g versus i, h versus i,
and i versus j); p > 0.1 (f versus g, f versus h, f versus j, g versus h, g versus j,
and h versus j). Differences between the same organs of both mouse strains
were significant in all cases (a versus f, b versus g, c versus h, d versus i,
and e versus j, all p < 0.005).and Hc to the total virus load in organs of Tie2-cre and Alb-cre
mice, respectively, was only marginally affected by infection
dose (FiguresS5AandS5B), by ageandgender (data not shown),
as well as by the route of systemic infection (Figure S5C). After
mucosal infection, the same hierarchy of organ-specific rele-
vance of EC to virus production was seen (Figure S5D). Collec-
tively, these data document that Cre-based conditional muta-
genesis can reveal virus productivity in vivo in a cell-type
specific manner.
EC and Hc Are Direct and Productive Targets of MCMV
In vitro, one round of MCMV replication in fibroblasts takes
24 hr, but the time required for replication in specific cell types
in vivo was so far only a matter of guess. Following i.v. infection,
EC are directly exposed to the virus. Provided that EC can serve
as direct target cells of productive infection and that the replica-
tion cycle in EC in vivo is comparable, we expect the first appear-
ance of MCMV-rec in Tie2-cremice24 hr. In contrast, since Hc
are separated from the circulation by the liver endothelium, one
might expect that an Hc-derived progeny in Alb-cre mice be-
comes detectable only after a first replication cycle in EC. To
find out when EC and Hc actually give rise to a labeled progeny,
to determine their quantitative contribution to the virus load, and
to follow the fate of MCMV-rec during acute infection, Tie2-cre
and Alb-cre mice, respectively, were infected and organs were
analyzed between 1 and 7 days p.i. (Figure 3).
MCMV-flox generated in the first round of replication is indis-
tinguishable from input virus, butMCMV-rec identifies the contri-
bution of Cre-expressing cell types. At day 1 p.i., EC-derived
MCMV-rec became apparent only in the spleen of Tie2-cre
mice (Figures 3Aa–3Af). At 32 hr p.i., however, it was routinely
found in the spleen and sporadically now also in lungs and heart
(Figures 3Ba–3Bc). Since 24 to 32 hr are too short for two rounds
of replication, these findings imply that EC indeed represent di-
rect and productive target cells at least in spleen, lungs, and
heart. At day 2 p.i., MCMV-rec was reliably detectable in most
organs tested (Figures 3Aa–3Ad), including the blood (Fig-
ure 3Af). Although EC are a frequent cell type in the liver, EC-
derived MCMV-rec contributed only little to the overall liver virus
load (Figure 3Ae).
Hc are separated from the circulation by the liver endothelium.
It was therefore a surprise to consistently find a high proportion
of MCMV-rec in Alb-cremice already 24 and 32 hr after i.v. infec-
tion (Figures 3Ak and 3Bd) and even after infection with low
doses of virus (Figure 3Be). This implies that MCMV efficiently
crosses the liver endothelium without a prior replication cycle
in EC. In conclusion, the data show for the first time that Hc
are a prominent and productive, direct target for MCMV distrib-
uted via primary viremia.
EC- but Not Hc-Derived Virus Contributes
to Secondary Viremia
HCMV DNA is frequently recovered from peripheral blood of pa-
tients with disseminated infection, and MCMV can also be iso-
lated from blood of infected mice (Wu and Ho, 1979). In patients
with active CMVdisease, ECwere proposed to disseminate virus
also in the form of detached, infected cells (Gerna et al., 2004).
The experimental design gave us the opportunity to evaluate
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titers was very low. We found a high percentage of EC-derived
virus in the blood of Tie2-cre mice between 2 and 5 days p.i.
(Figure 3Af; Figures S2 and S5C). Although, on average, EC-de-
rived MCMV-rec accounted for 50%–80% of the total virus load
in blood, it apparently contributed little to the overall virus load in
the liver (Figure 3Ae; Figures S2 and S5C), and at least some of
the MCMV-rec PFU isolated from liver may be derived from the
blood circulation, in particular on day 5 (Table S1). This finding
implies that liver EC, unlike the EC in other organs, are poor
producers during primary infection. Furthermore, the already
infected liver was not superinfected by blood-born EC-derived
MCMV-rec in the course of secondary viremia to a significant ex-
tent. Analogous findings were obtained under conditions of low
primary viremia (recall Figure S5A) and with an independent,
floxed mutant of MCMV, namely MCMV-Dm128-flox-egfp
(data not shown). Thus, the lack of liver superinfection by
blood-born EC-derived MCMV-rec is not due to the infectious
dose or by an unknown effect of the deletion of m157. The
high ratios of EC-derived MCMV-rec achieved already during
primary infection in organs other than liver (Figures 3Aa–3Ad)
make it difficult to judge the contribution of secondary viremia
in these organs. Here the direct contribution of blood-born
MCMV-rec is negligible (Table S1).
Whereas EC are present in all organs, the Alb-cre model has
the distinctive advantage that the cellular source of recombined
virus is restricted to a single organ, representing the ideal situa-
tion for studying virus dissemination from a defined site (Figures
Figure 3. Relevance of EC and Hc in Production and Dissem-
ination of MCMV
(A) Tie2-cre+/ (Aa–Af) and Alb-cre+/+ mice (Ag–Al) were infected with
106 PFU of MCMV-flox i.v., and spleen (Aa and Ag), lungs (Ab and Ah),
heart (Ac and Ai), kidney (Ad and Aj), liver (Ae and Ak), and blood
(Af and Al) of three mice per time point were analyzed on days 1, 2,
3, 5, and 7 p.i. as described in Figure 1B. Similar data were obtained
in ten independent experiments altogether per mouse line, with most
time points being represented repeatedly.
(B) Tie2-cre+/ (Ba–Bc) and Alb-cre+/ (Bd) mice were infected with
106 PFU of MCMV-flox i.v., and spleen (Ba), lungs (Bb), heart (Bc),
and liver (Bd) were analyzed 32 hr p.i. Results of individual mice
from four independent experiments (I–IV) are shown. In (Be), groups
of Alb-cre+/ mice were infected with the indicated PFU doses of
MCMV-flox i.v., and organs were analyzed 32 hr after infection.
3Ag–3Al). Most remarkably, although Hc represent a
direct target cell type producing MCMV-rec (Figure 3Ak)
with rapid kinetics preceding the virus peak in most other
organs (Figures 3Ag–3Aj), and although the liver is the
main contributor to the total virus load in the mouse
(99.4% at 32 hr p.i.; Figure S6), Hc-derived MCMV-rec
was only occasionally and transiently released into the
circulation in low amounts visible on day 2 p.i. (Figure 3Al).
In accordancewith this, Hc-derivedMCMV-rec did not ef-
ficiently colonize spleen, lungs, heart, and kidney (Figures
3Ag–3Aj). This finding excludes Hc as a source of virus
dissemination. The lack of dissemination proved to be
independent of virus dose, as the same phenotype was
seen for a dose range between 4 3 104 and 5 3 106
PFU of MCMV-flox (Figure S5B). The possibility that rep-
lication in Hc alters the cell-type tropism of the virus progeny by
adaptation was ruled out by the finding that MCMV-rec isolated
from the liver of Alb-cre mice was not attenuated for growth in
spleen and lungs in comparison to MCMV-flox after infection
of C57BL/6 mice (Figure 4). It is important to note that the i.v. in-
fection route used for an experimental primary viremia was not
responsible for the lack of dissemination because Hc-derived
MCMV-rec failed to disseminate to other organs also in Alb-cre
mice infected locally via the footpad or the mucosal route (Fig-
ure 5). In conclusion, virus generated in Hc is not disseminated
at the time of secondary viremia.
Bidirectional Spread of MCMV between EC
and Hc within the Liver
After the first round of replication, the labeled virus progeny can
spread to other permissive cell types, which could then account
for thebulk of virus productivity. Thecellular site of recombination
is, thus, not necessarily also the cellular site of major virus pro-
duction during subsequent rounds of virus replication. Although
virus isolated from the liver is clearly able to replicate in other
organs (Figure 4), it is apparently not released in larger amounts
from the liver into the blood stream under physiological condi-
tions. Limited ability of Hc-produced virus to infect neighboring
non-Hc (e.g., EC) to finally reach the blood circulation is one
possibility to be considered. This question was experimentally
addressed by combining in the same experiment the quantifica-
tion of MCMV-rec-infected cells by two-color immunohistology
(Figures 6A and 6B) and the quantification of liver cell-derived
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Virus Replication and Dissemination In VivoMCMV-rec (Figure 6C). Up to day 2 after i.v. infection of Tie2-cre
and Alb-cre mice with MCMV-flox, the presence of MCMV-rec
was found tobe largely restricted to thecognate cell type (Figures
6Aa, 6Ab, and 6B). Notably, only one day later, MCMV-rec had
spread to the respective noncognate cell type, that is, from EC
to Hc in the Tie2-cre liver (Figure 6Ac) and from Hc to EC in the
Alb-cre liver (Figure 6Ad). Thus, both cell types generate virus
for spread. The quantification of cells infected with MCMV-rec,
that is, double-stained IE1+EGFP+ cells of both cell types, high-
lights this spread by showing a decrease in the relative numbers
of infected direct targets and a corresponding increase in the
numbers of infected secondary (and tertiary) targets between
days 2 and 3 (Figure 6B).
With respect to the number of infected cells, the infection was
almost resolved in both transgenic mouse lines by day 5 in this
experiment, although residual infectivity may persist for a longer
period in the form of free virions (Figures 6B and 6C; for variability
of virus clearance see also Figures S1 and S7). The rapid clear-
ance of infected cells coincided with the infiltration of CD33-
positive T cells followed by resolution of the tissue infection
(Figure 6D).
Hc Contribute to Liver Virus Load Mainly as the First
Targeted Cell Type
Comparison of both Cre transgenic mouse lines with regard to
the number of EGFP+ cells per tissue section area (Figure 6B)
and the corresponding titer of MCMV-rec on day 1 and 2 (Fig-
ure 6C) provided clear evidence that liver EC, comprising mainly
liver sinusoidal EC (LSEC), are poor producers of infectious virus,
whereas Hc are highly productive. Remarkable and very infor-
mative is the situation on day 3. At that time point we found an
3-fold higher number of EGFP+ Hc compared to EGFP+ EC in
both mouse strains (Figure 6B), yet the contribution of MCMV-
rec remained low in livers of Tie2-cre (Figures 6C and 3Ae) and
Tek-cremice (data not shown). Thus, although Hc are productive
direct targets as shown in the Alb-cre model, the delayed sec-
ond-round infection of Hc by MCMV-rec derived from EC in
Tie2-cre livers contributed little to total infectivity and did only
slightly exceed the contribution of circulating MCMV-rec (Table
S1). This is probably due to the onset of CD3+ T cell control (Fig-
ure 6D). It is instructive to note that onset of immune control
followed the same kinetics in both mouse lines and affected
MCMV-rec titers and total MCMV titers alike (Figures 6C and
6D). Taken together, these data prove that the histological evi-
dence for infection of a cell type does not allow any definite
conclusion with regard to virus productivity by that cell type at
a given time of infection.
Failure of Hc-Derived Virus to Disseminate Even
under Conditions of Immunosuppression
or Proinflammatory Stimulation
Selective T cell infiltration into EGFP+ foci of EC and Hc coincid-
ingwith the resolution of histologically detectable infection within
5 days (Figure 6D) suggested that the immune response elimi-
nates infected EGFP+ cells in the liver. This might also be the
mechanism that limits the chance to disseminate MCMV-rec
from the liver to other sites. To test this hypothesis, Alb-cre
mice were immunosuppressed by whole-body g-irradiation
2 days after infection. In accordance with the proposed immune
control, the total virus titers increased by up to three orders of
magnitude in organs and by one order of magnitude in the blood
(Figure 7A, group 1 versus groups 2 and 3). Yet, still no liver-de-
rived MCMV-rec appeared in blood, spleen, lungs, or salivary
glands 3 and 6 days after irradiation (Figure 7A, groups 2 and
3, respectively). Similarly, the combined damage of liver endo-
thelium and immunosuppression caused by cyclophosphamide
Figure 4. Hc-DerivedMCMVHas the Potential to Replicate in Spleen
and Lungs
Four Alb-cre+/ mice were infected i.v. with 106 PFU of MCMV-flox. At 2 days
p.i., a virus stock was generated from pooled livers (Li-VS), and the ratio of
MCMV-rec was determined. This virus stock was used to infect 5 C57BL/6
mice with 1.5 3 104 PFU i.p., and lungs (lu) and spleen (sp) were analyzed
on day 3 p.i. as described in Figure 1B.
Figure 5. The Failure of Hc-Derived Virus to Leave the Liver Is Inde-
pendent of the Route of Infection
Alb-cre+/ mice were g-irradiated with 6 Gy and infected with 105 PFU of
MCMV-flox in (A) the right hind footpad (f.p.) or (B) intranasally (i.n.) with 106
PFU of MCMV-flox. Liver (li), blood (bl), spleen (sp), lungs (lu), kidney (ki), heart
(he), and salivary glands (sg) were analyzed as described in Figure 1B on day
12 p.i. (A) or on days 4, 8, 12, and 16 p.i. (B).
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concanavalin A (group 5), which is known to increase vascular
permeability (Tiegs et al., 1992) or immunosuppression by com-
bined depletion of NK cells as well as of CD4 and CD8 T cells
(Figure 7B), all failed to facilitate dissemination of MCMV-rec.
As depletion of CD4 T cells is known to also prevent the produc-
tion of MCMV-specific antibodies (Jonjic et al., 1989) adaptive
humoral immunity does not seem to be involved either.
The disruption ofm157 in the viral genome cannot explain the
dissemination defect, as a reporter virus containing the Cre-in-
ducible EGFP-expression cassette within the m128 locus also
proved to be unable to disseminate from livers of immunosup-
pressed mice (Figure 7B). Accordingly, it has been reported that
an MCMV mutant containing a GFP-expressing cassette within
m128 is able to induce secondary viremia and salivary gland
infection indistinguishable from MCMV-WT (Saederup et al.,
2001). These findings are a strong argument against detrimental
effects of the disrupted gene or expression of GFP on virus dis-
semination. In addition, MCMV-flox and MCMV-rec replicate to
similar titers in C57BL/6 and Alb-cre mice excluding a defect in
Alb-cremice caused by Cre expression or by transgene insertion
into themousegenome (FigureS7). Taken together, thedata sug-
gest that dissemination of MCMV from the liver to other organs is
not preventedby a barrier function of the liver endothelium, byNK
cells, or the adaptive immune response. Collectively, our data
give the important new information that in the case of MCMV in-
fection, in contrast to long-held concepts of virus dissemination
by secondary viremia, liver-derived virus does not contribute to
the colonization of other target organs of virus disease.
DISCUSSION
Here, we show that conditional virus labeling in vivo can be used
to analyze the contribution of specific cell types to virus produc-
tionanddissemination in thehost, both important aspectsof virus
pathogenesis. We provide the following new information. First,
hepatocytes (Hc) and vascular endothelial cells (EC) are primary
and productive target cells for MCMV in vivo. Second, the contri-
bution of EC to productive infection reveals prominent differ-
ences between organs. Third, Hc contribute to liver virus load
mainly as the first targeted cell type. Finally, the finding of spread
within liver tissue combinedwith the finding that the liver does not
contribute to virus dissemination during acute infection provided
unexpected insights that challenge generally held concepts.
Quantification by the Cre/loxP depends on efficient recombi-
nation of virus genomes in infected Cre expressing cells. Hemi-
zygous Alb-cre mice harbour 9 (Postic et al., 1999) and Tie2-
cre as well as Tek-cre mice harbour 30 to 40 copies (data not
shown) of the transgene, so that Cre expression should not be
a limiting factor, in particular if we consider that recombination
of a single viral genome is likely to be sufficient for production
of recombined progeny. Evidence in support of this is provided
in Alb-cre mice in which after the first round of infection already
70% of virus was found to be recombined. Accordingly, no
gene dose effect on the recombination rate was observed in
livers of hemizygous and homozygous Alb-cre mice.
In Tie2-cre mice, organs differ with respect to the rate of
recombined virus. In liver, the lowest amount of EC derived prog-
eny was found. Yet, as Hc were identified to produce about 70%
Figure 6. Bidirectional Spread of MCMV between EC and Hc
Histological analysis was performed on liver tissue sections derived from Tie2-
cre+/ and Alb-cre+/+ mice of the experiment of Figure 3A. Livers from three
mice per group and time point were analyzed on days 1, 2, 3, and 5 after infec-
tion with MCMV-flox for the presence of cells infected with MCMV-rec and for
the presence of CD3+ cells.
(A) Two-color IHC analysis for intranuclear IE1 protein (black) and cytoplasmic
EGFP (red). Double staining identifies cells infected with MCMV-rec. EC were
identified according to morphological criteria confirmed by CD31 and LYVE-1
IHC staining (data not shown). The bar marker represents 50 mm.
(B) Quantification of double-stained EC andHc in a representative 60mm2 liver
tissue section area (3000-fold the area represented in themicrophotographs)
compiled from the threemice per group. Pie chart segments represent propor-
tions of IE1+ EGFP+ EC (light red) and IE1+ EGFP+ Hc (dark red). Numbers
above and below the pie charts represent the absolute cell count of IE1+
EGFP+ EC and IE1+ EGFP+ Hc, respectively. Asterisk indicates infection histo-
logically cleared.
(C) Load of MCMV-rec (red) and total virus (black) in livers of Tie2-cre+/ and
Alb-cre+/+ mice in absolute terms. The same data are shown in Figures 3Ae
and 3Ak.
(D) Infected liver cells and liver-infiltrating T cells were identified by two-color
IHC analysis of EGFP (red) and CD33 (black) expression, respectively. The bar
marker represents 100 mm.
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30%. In organs with a high percentage of MCMV-rec, as in lungs
and heart, Cre expression was apparently no significant limita-
tion for recombination. We, therefore, believe that the hierarchy
of EC contribution to total organ virus load is rather determined
by intrinsic differences in the productivity of organ-specific EC
subpopulations. It is known that organ-specific EC differ in phe-
notype, function, and number (Garlanda and Dejana, 1997), and
EC derived from specific tissues differ with regard to HCMV rep-
lication in vitro (Jarvis and Nelson, 2007).
Infected EC are thought to contribute to viremic dissemination
by serving as transport vehicle and by uptake and release of virus
(Knipe and Howley, 2001). Chronic CMV infection of vascular
tissues is discussed as a potential trigger in the process of
atherosclerosis. EC isolated from different vascular beds sup-
port lytic and productive CMV replication in vitro (Jarvis and Nel-
son, 2007). Infected EC were identified in several organs by his-
tology and were found to express late viral antigens suggestive
of virus production (Gerna et al., 2004). We confirm and extend
these findings by presenting definite evidence for the productive
infection of EC by CMV in vivo. Wewere also able to estimate the
contribution of the EC-derived progeny to the total virus load in
organs. Of course, this contribution of EC to virus production
holds only for the first replication round from about 24 to 32 hr
postinfection. At later times, a high percentage of an EC-derived
progeny could mean that EC continue to produce virus; that
other cell types infected in further rounds by the labeled virus
progeny, for instance various types of epithelial cells, take
over, and dominate the infection; or that viruses produced in
the first round in other cell types acquire the label upon second-
ary infection of EC. In any case, the high percentage of MCMV-
rec in most organs of Tie2-cre mice impressively underscores
the outstanding importance of a passage through EC barriers
in the colonization of important organ sites of CMV disease man-
ifestations, the lungs in particular. In spleen and liver, however,
peak titers are reached already after 2 days until immune control
limits further replication. At such an early time point, the primary
target cell types are likely to still contribute most to the virus load
as illustrated herein for the Hc of the liver. In contrast, in organs in
which the virus load peaks at much later time points, as it is the
case for lungs, heart, kidney, and salivary glands, secondary tar-
get cell types may predominate. In the specific example of the
persisting infection of the salivary glands, it is well documented
that a low number of highly productive acinar epithelial cells
can account for the virus load (Jonjic et al., 1989).
In many systemic virus infections, the liver is a major target or-
gan (Flint, 2004), and the liver acts as a filter for viruses, with ad-
enovirus being a well-known example (Glasgow et al., 2006).
HCMV hepatitis is a frequent complication in the immunocom-
promised patient and can occur even in immunocompetent
individuals. Hc support productive infection in organ cultures
(Sinzger et al., 1999). Here, we provide in vivo evidence for Hc
representing a direct producer cell type dominating virus pro-
duction in the liver and the whole body early in infection. The in-
fection kinetics revealed that the LSEC have no barrier function
for CMV infection of the parenchymal Hc. The liver sinusoidal
endothelium is discontinuous, fenestrated, and lacks a basal
lamina and tight junctions. It, therefore, might allow direct entry
of virion particles. Alternative pathways are transcytosis (Tuma
and Hubbard, 2003) and paracellular transport between liver
EC facilitated by inflammatory processes. Transcytosis through
LSEC is a transcellular (vesicular) transport that has already been
suggested for other hepatotropic viral infections (Cormier et al.,
2004; Breiner et al., 2001).
Hematogenous dissemination is a crucial step in many sys-
temic infections. Besides leukocytes, EC are suggested to play
an important role for CMV dissemination. Viremic virus can be
derived from productively infected EC in the endothelia or from
detached circulating EC (Gerna et al., 2004). It can be associated
with leukocytes (Stoddart et al., 1994) that received the virus
from EC, or it can move as cell-free virion (Wu and Ho, 1979).
Here, we provide formal evidence for the contribution of EC to
secondary viremia. It has been suggested that placenta and
fetus (Griffith et al., 1990) as well as salivary glands (Saederup
et al., 2001) are colonized by secondary viremia. The conditional
model described here might be helpful with studying the origin of
disseminated virus in greater detail.
Liver and spleen are regarded as being major sources for virus
dissemination during secondary viremia. This concept, originally
developed by Frank Fenner for the example of poxviruses (Fen-
ner, 1949), was then also generally accepted for other systemic
virus infections (Flint, 2004), including MCMV (Collins et al.,
1994). The model is based on the observation that virus produc-
tion in liver and spleenprecedes secondary viremia, antigenemia,
DNAemia, and colonization of other organs. Formal proof of this
origin of virus during secondary viremia has never been provided,
however. Here, we show that CMV produced in Hc does neither
contribute significantly to secondary viremia nor to dissemination
of the infection to other organs. This applies to dissemination via
free or cell-associated virus and to all conditions tested. This
Figure 7. Lack of Dissemination of Hc-Derived MCMV Is
Independent of Immune Control andm157 Gene Deletion
(A) Two days after i.v. infection with 5 3 105 PFU of MCMV-flox,
Alb-cre+/mice were left untreated (1) or were treated with g-irra-
diation (2 and 3), cyclophosphamide (4) or concanavalinA (5). The
analysis was performed 5 days (1, 2, 4, and 5) or 8 days (3) p.i. as
described in Figure 1B.
(B) Untreated () and immunodepleted (+) Alb-cre+/ mice were
infected i.v. with 106 PFU of MCMV-Dm128-flox, and organs
were analyzed 10 days p.i. as described in Figure 1B. Immunode-
pletion was performed by i.p. application of a-asialo-GM1, a-CD4,
and a-CD8 antibodies. The differences in viral titers between un-
depleted and depleted groups of mice are highlighted by shaded
columns. Sg, salivary glands. Asterisk indicates total virus titer
was too low to determine the contribution of MCMV-rec.
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infectious progeny in the body throughout the period of acute in-
fection. Thus, virus productivity in an organ and virus dissemina-
tion from this organ is not necessarily linked. The role of the
spleen in dissemination of MCMV via secondary viremia is still
open to question.
Whichmechanismscould account for the lackof dissemination
of liver-derived MCMV? Inability of spread between cells is ap-
parently not the mechanism, since Hc-derived virus was found
to spread efficiently to another cell type, namely EC, and likewise,
liver EC-derived virus spread to Hc. Nevertheless, although oc-
casional detection of Hc-derived MCMV in blood showed that
the export block was not absolute, the virus that was released
from the liver did not colonize other organs. Even after immuno-
suppression that increased the virus load in the liver byup to three
orders of magnitude or after treatment of mice with regimens
affecting the integrity of liver endothelium, there was no virus col-
onization of other organs. This lack of dissemination from the liver
not only applies to intravenous infection, a route of infection that
reflects the important medical situation of blood transfusion, but
also to local infection. Collectively, our data have excluded a con-
tribution of adaptive immunity, of NK cells, and of radiosensitive
mechanisms to the block in virus dissemination from the liver. It
is well known that type I interferons play amajor role in controlling
CMV infection (Hengel et al., 2005). Perhaps the local innate
inflammatory cytokine response blocks recolonization of an
already infected organ during secondary viremia. These inflam-
matory conditions caused by MCMV are known to affect the
infection by other pathogens (Barton et al., 2007). Only specific
situations, such as the transplantation of an infected organ into
a naive recipient, a local reactivation event from latency, or a ge-
netic deficiency in the cytokine responsewould predispose an in-
dividual to those variable disease and dissemination conditions
as they are seen in HCMV infection. It shall be attractive to exploit
the conditional approach in mice deficient for specific functions,
such as defects that cause vascular diseases (Presti et al., 1998;
Hsich et al., 2001) associatedwithHCMV infection. The same ap-
plies to studies with MCMV mutants with defects in viral genes
that modulate the host immune response (Scalzo et al., 2007).
The characterization of cell-type-specific functions of viral genes
in vivo will help to better understand virus-host interactions.
EXPERIMENTAL PROCEDURES
Cells and Mice
M2-10B4 (CRL-1972; ATCC) and BALB/c-derived mouse embryo fibroblasts
(MEF) were grown as described (Cicin-Sain et al., 2005). All animals were
housed at the animal facility of the Max-von-Pettenkofer Institute and at
RCC, Switzerland, under specified-pathogen-free (SPF) conditions. Trans-
genic Alb-cre (Postic et al., 1999), Tie2-cre (Constien et al., 2001; kindly pro-
vided by B. Arnold, DKFZ, Heidelberg, Germany), and Tek-cre (Koni et al.,
2001) mice were maintained on the C57BL/6J background. C57BL/6J mice
were obtained from Harlan-Winkelmann and B6.SJL-Ptprc (Ptprc), Alb-cre,
and Tek-cre mice from Jackson Laboratories. Experiments were performed
with male and female mice at 3 to 18 months of age. Animal experiments
were approved by the responsible state office.
Viruses and Infection of Mice
All viruses were derived from the molecular clone pSM3-fr (Wagner et al.,
1999). Mutant viruses were generated as described below. Viruses were prop-
agated onM2-10B4 cells and purified as described (Cicin-Sain et al., 2005). To
270 Cell Host & Microbe 3, 263–272, April 2008 ª2008 Elsevier Inc.prepare virus stock from livers, four Alb-cremice were infectedwith 106 PFU of
MCMV-flox i.v., and livers were taken 48 hr p.i., homogenized, pooled, and fur-
ther prepared similar to cell culture-derived virus, except that no gradient-den-
sity purification was performed. Virus quantification was done by standard
plaque titration assay on MEF. Mice were infected intraperitoneally (i.p.) or in-
travenously (i.v.; into a tail vein) in a volume of 300 ml, subcutaneously (s.c.) into
the right hind footpad, or intranasally (i.n.) in a volume of 25 ml.
Construction of Recombinant Viruses
The EGFP encoding BamHI/XbaI fragment from N1-EGFP (Clontech) was in-
serted into corresponding sites of pCR3 (Invitrogen) between the major imme-
diate early promoter of HCMV and the polyA signal of bovine growth hormone
(pA) to obtain pCR3-egfp. Into the BssHII site of pCR3-egfp blunted by mung
bean nuclease (MBN), the 1.4 kbp SmaI fragment of pCP15 carrying the FRT
flanked kanamycin resistance gene (kanr) was introduced resulting in pCR3-
FRT-kanr-FRT-egfp. A 1 kbp EcoRI fragment encompassing the 30 end of
the lacZ gene and a SV40 polyA signal flanked by loxP sites was cloned into
the HindIII site of pCR3-FRT-kanr-FRT-egfp between promoter and egfp after
MBN treatment resulting in pCR3-FRT-kanr-FRT-flox-egfp. To obtain a con-
struct with constitutively active egfp, the floxstop cassette was removed by
electroporation of 705-cre bacteria with pCR3-FRT-kanr-FRT-flox-egfp result-
ing in pCR3-FRT-kanr-FRT-rec-egfp. The IEP-flox-egfp cassette together with
the FRT flanked kanr was amplified by PCR using primer 50-Dm157-flox-egfp
(50-CGT GGT CAA GCC GGT CGT GTT GTA CCA GAA CTC GAC TTC GGT
CGC GTT TTA ACG CTT ACA ATT TAC GGG GG-30) and primer 30-Dm157-
flox-egfp (50-CCC CGA TAT TTG AGA AAG TGT ACC CCG ATA TTC AGT
ACC TCT TGA CTA AGA AGC CAT AGA GCC CAC CGC-30). The site-directed
insertion of the PCR fragments into pSM3fr was performed by recombination
with linear fragments (Wagner and Koszinowski, 2004). Construction of
pSM3fr-Dm157-flox-egfp-FRT-kanr-FRT and pSM3fr-Dm157-rec-egfp-FRT-
kanr-FRT was confirmed by restriction enzyme digest analysis and sequenc-
ing. After removal of kanr, MEF were transfected with pSM3fr-Dm157-flox-
egfp and pSM3fr-Dm157-rec-egfp to reconstituteMCMV-flox andMCMV-rec,
respectively. The generation of MCMV-Dm128-flox (former designation
loxPGFP-MCMV) has been described (Cicin-Sain et al., 2005).
Determination of Infectious Virus in Organs
Virus load in organs was determined as described previously (Cicin-Sain et al.,
2005), with the modification that organ homogenates were centrifuged before
dilution at 8603g for 3min. Bloodwas collected in 100 ml 200mMEDTA in PBS
and stored at80C. After thawing, blood sampleswere added toMEF directly
in a volume of 15 ml per well. The numbers of MCMV-rec and MCMV-flox PFU
were determined from organ homogenates after 4 days and from blood after
5 to 6 days using a fluorescence microscope (Olympus). Only plaques visible
in bright field were considered for the calculation. PFU were calculated per
ml blood or g organ or per organ.
Generation of Bone Marrow Chimeras
Female recipient Tie2-cre (CD45.2) or nontransgenic Ptprc (CD45.1) mice were
g-irradiated twice with 5.5 Gy delivered by a 137Cs source. One day after irra-
diation, recipients received 23 106 bone marrow cells i.v. derived from sex of
matched Tie2-cre or Ptprc donors. Eight weeks after bone marrow transplan-
tation, cytofluorometric analysis was performed on peripheral blood cells
using CD45.1-PE (Chemicon), CD45.2-PerCP-Cy5.5, CD4-FITC, and CD8-
FITC (all BD-PharMingen) antibodies. Less than 4% residual recipient cells
were determined in the CD4CD8 population. Nine weeks after the transplan-
tation, mice were infected i.p. with 5 3 106 PFU MCMV-flox.
Two-Color Immunohistological Analysis
Paraffin-embedded 2 mmsections of liver tissue were labeled for nuclear IE1 or
cell membrane CD3 by using mouse mAb CROMA 101 specific for IE1 (kindly
provided by S. Jonjic, Rijeka, Croatia) or rat mAb CD3-12 (NovoCastra),
followed by biotinylated goat-anti-mouse Ig and biotinylated goat-anti-rat Ig,
respectively. Black staining was achieved with DAB as the peroxidase sub-
strate and ammonium-nickel-sulfate hexahydrate for signal enhancement.
For subsequent labeling of EGFP, sections were incubated with polyclonal
rabbit Ig directed against GFP followed by AP-conjugated IgG1 mAb (clone
RG-16, Sigma) specific for rabbit-Ig. After incubation with the rabbit-APAAP
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gen kit. Light counterstaining was performed with hematoxylin.
Immunosuppressive and Proinflammatory Treatments
NK, CD4, and CD8 cells were depleted by i.p. administration of 40 ml of rabbit
a-asialoGM1 (Waco Chemicals), 1 mg of a-CD4 (YTS 191.1.2), and 1 mg of
a-CD8 (YTS 169.4.2) antibodies, respectively, 1 day prior to infection as well
as 4 days and 7 days p.i. Depletion of at least 90% of the respective cell
population was confirmed by flow cytometry.
Total body g-irradiation was performed in a single dose of 6 Gy by using
a 137Cs source, delivering a dose rate of 63.6 cGy/min. Four mg cyclophos-
phamide (Endoxan, Baxter) or 0.2 mg concanavalin A (Sigma) was diluted in
PBS and injected i.v. in a volume of 300 ml.
Statistical Analysis
Comparison of percentage of recombined virus between organs was done
with the two-tailed Wilcoxon rank sum test using website http://elegans.
swmed.edu/leon/stats/utest.cgi. A p value < 0.05 was considered as signif-
icant difference, and a p value > 0.1 was considered as no significant
difference.
SUPPLEMENTAL DATA
The Supplemental Data include seven supplemental figures and one sup-
plemental table and can be found with this article online at http://www.
cellhostandmicrobe.com/cgi/content/full/3/4/263/DC1/.
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